Prognostic Implications of Elevated Cardiac Troponin T in Patients with Acute Ischemic Stroke
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Elevated cardiac troponin T (cTnT) levels have been reported in patients with acute ischemic stroke, however, the prognostic relevance is not well established. We evaluated the association between cTnT elevation and prognosis in patients with acute ischemic stroke. Methods: The 182 consecutive patients enrolled had new-onset acute ischemic stroke. Their clinical and laboratory findings were collected retrospectively. Stroke severity and prognosis were determined using the National Institutes of Health Stroke Scale (NIHSS) and the modified Rankin Scale (mRS) scores, as well as 30-day all-cause mortality. The patients were divided into two groups according to their cTnT levels: ≤14 and >14 ng/L. Cox proportional hazards regression analysis was performed to determine the associations between clinical or laboratory variables and 30-day all-cause mortality. The Kaplan–Meier method was used to compare the overall survival rate in patients with elevated and normal cTnT levels. Results: The cTnT level was elevated in 14.8% of the patients. Age, NIHSS and mRS scores, creatinine kinase-MB, and 30-day all-cause mortality were significantly higher in patients with elevated cTnT levels than in those with normal cTnT levels. The hazard ratio of the elevated vs. normal cTnT group for 30-day all-cause mortality was 8.06 (95% confidence interval: 1.13–57.25, P=0.037). A Kaplan–Meier survival analysis revealed a significantly higher survival rate in patients with normal cTnT levels compared to those with elevated cTnT levels (P<0.0001). Conclusions: An elevated cTnT level is significantly associated with poor short-term outcomes in patients with acute ischemic stroke.
Abstract
Background: Elevated cardiac troponin T (cTnT) levels have been reported in patients with acute ischemic stroke, however, the prognostic relevance is not well established. We evaluated the association between cTnT elevation and prognosis in patients with acute ischemic stroke. Methods: The 182 consecutive patients enrolled had new-onset acute ischemic stroke. Their clinical and laboratory findings were collected retrospectively. Stroke severity and prognosis were determined using the National Institutes of Health Stroke Scale (NIHSS) and the modified Rankin Scale (mRS) scores, as well as 30-day all-cause mortality. The patients were divided into two groups according to their cTnT levels: ≤14 and >14 ng/L. Cox proportional hazards regression analysis was performed to determine the associations between clinical or laboratory variables and 30-day all-cause mortality. The Kaplan–Meier method was used to compare the overall survival rate in patients with elevated and normal cTnT levels. Results: The cTnT level was elevated in 14.8% of the patients. Age, NIHSS and mRS scores, creatinine kinase-MB, and 30-day all-cause mortality were significantly higher in patients with elevated cTnT levels than in those with normal cTnT levels. The hazard ratio of the elevated vs. normal cTnT group for 30-day all-cause mortality was 8.06 (95% confidence interval: 1.13–57.25, P=0.037). A Kaplan–Meier survival analysis revealed a significantly higher survival rate in patients with normal cTnT levels compared to those with elevated cTnT levels (P<0.0001). Conclusions: An elevated cTnT level is significantly associated with poor short-term outcomes in patients with acute ischemic stroke.
참고문헌 (20)
- Keun-Sik Hong, "Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke", 대한뇌졸중학회지, 15(1), pp.2~20 (2013), 대한뇌졸중학회[DOI]
- Sherwood MW, "High-sensitivity troponin assays: evidence, indications, and reasonable use", J Am Heart Assoc, 3, pp.e000403~ (2014)
- Suk Jae Kim, "Biomarkers for Stroke", 대한뇌졸중학회지, 15(1), pp.27~37 (2013), 대한뇌졸중학회[DOI]
- Kerr G, "Elevated troponin after stroke: a systematic review", Cerebrovasc Dis, 28, pp.220~226 (2009)
- Di Angelantonio E, "Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke", J Neurol Neurosurg Psychiatry, 76, pp.76~81 (2005)
- 송화석, "Cardiac Troponin T Elevation After Stroke: Relationships Between Elevated Serum Troponin T, Stroke Location, and Prognosis", Journal of Clinical Neurology, 4(2), pp.75~83 (2008), 대한신경과학회
- Faiz KW, "Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke", J Stroke Cerebrovasc Dis, 23, pp.241~248 (2014)
- Barber M, "Elevated troponin levels are associated with sympathoadrenal activation in acute ischemic stroke", Cerebrovasc Dis, 23, pp.260~266 (2007)
- Etgen T, "Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis", Stroke, 36, pp.270~275 (2005)
- Jensen JK, "Highly sensitive troponin T in patients with acute ischemic stroke", Eur Neurol, 68, pp.287~293 (2012)
- Saenger AK, "Multicenter analytical evaluation of a high-sensitivity troponin T assay", Clin Chim Acta, 412, pp.748~754 (2011)
- Anders B, "What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients?", Cerebrovasc Dis, 36, pp.211~217 (2013)
- Král M, "Troponin T in acute ischemic stroke", Am J Cardiol, 112, pp.117~121 (2013)
- Stahrenberg R, "High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia", J Neurol Neurosurg Psychiatry, 84, pp.479~487 (2013)
- Jensen JK, "Mechanism of troponin elevations in patients with acute ischemic stroke", Am J Cardiol, 99, pp.867~870 (2007)
- Jensen JK, "Frequency and significance of troponin T elevation in acute ischemic stroke", Am J Cardiol, 99, pp.108~112 (2007)
- Christensen H, "Serum cardiac troponin I in acute stroke is related to serum cortisol and TNF-alpha", Cerebrovasc Dis, 18, pp.194~199 (2004)
- Jespersen CM, "Myocardial stress in patients with acute cerebrovascular events", Cardiology, 110, pp.123~128 (2008)
- Folsom AR, "Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study", Stroke, 44, pp.961~967 (2013)
- Oluleye OW, "Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality", Ann Epidemiol, 23, pp.66~73 (2013)